Showing results (91-100 of 232) with videos related to
Sort By:
Pageof 24
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1995
Changing role of carbapenems in the treatment of lower respiratory tract infectionsH Lode, J Hamacher, J Eller, et al.Arzneimittel-Forschung|January 1, 1980
[Doxycycline pellets: a suitable formulation with guaranteed bioequivalence]B Hampel, H Lode, H Fenner, et al.Antimicrobial Agents and Chemotherapy|December 1, 1982
Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage periodB Hampel, H Lode, J Wagner, et al.International Journal of Antimicrobial Agents|July 1, 1994
Use of fluoroquinolones in lower respiratory tract infections (LRTI)H Lode, T Schaberg, G Höffken, et al.APMIS. Supplementum|January 1, 1989
The pharmacokinetics of sultamicillinH Lode, B Hampel, G Bruckner, et al.Drugs|January 1, 1988
Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteersB Hampel, H Lode, G Bruckner, et al.Infection|January 1, 1977
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]H Lode, U Niestrath, P Koeppe, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1986
The pharmacokinetics of ticarcillin, clavulanic acid and their combinationG Höffken, H Tetzel, P Koeppe, et al.Critical Care (London, England)|May 17, 2001
Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen samplingH J Woske, T Röding, I Schulz, et al.Deutsche Medizinische Wochenschrift (1946)|February 26, 2005
[Pneumococcal vaccination in obstructive lung diseases -- what can we expect?]M Rose, H Lode, A de Roux, et al.Pageof 24